Knight Campus External Advisory Board

The Administrative Charge

The Knight Campus External Advisory Board draws on the expertise and knowledge of its members to advise the executive director on programs and policies. The board helps the executive director further the following goals: fast-tracking scientific discoveries into innovations that improve quality of life, training scientists, engaging in interdisciplinary research, forging tighter ties with industry and entrepreneurs, and creating new educational opportunities for graduate and undergraduate students; and enhancing the reputation of the Knight Campus among alumni, other institutions of learning, organizations, industry, colleagues, and community members. Board members also advise and assist in obtaining resources and financial support, particularly from corporate and private sources. 

Board Members

Cheryl Moody Bartel

As part of Thermo Fisher Scientific’s Chief Scientific Office, Cheryl currently leads Research & Development Operations, which includes fostering the ecosystem and community for the organization’s 5,000+ scientists and engineers. Managing tools, processes and analytics that promote excellence in new product development and effective commercialization are key day-to-day responsibilities. Additionally, Cheryl drives alignment for multi-disciplinary R&D initiatives and programs to capitalize on Thermo Fisher’s breadth of capabilities. In her previous role, she led several R&D teams

Jeanne Beacham

Jeanne Beacham is President and CEO of Delphon Industries LLC., a materials manufacturing company to the Semiconductor, Aerospace and Medical Industries. Delphon has Divisions Gel-Pak, TouchMark and UltraTape, with offices in Hayward and San Diego, CA, Wilsonville, Oregon, St. and Taiwan and global sales support. Jeanne joined Vichem Corporation in 1994 as Vice President of Marketing and Sales of GEL-PAK, responsible for worldwide sales, marketing, and strategic alliances. Delphon was named by the San Francisco Business Times as one of the Top Women-Owned Businesses in the Bay Area.

Eric Beckman

Eric Beckman received his Ph.D. in polymer science and engineering from the University of Massachusetts-Amherst in 1988. After postdoctoral research at Battelle’s Pacific Northwest Laboratory in 1987-88, Dr. Beckman assumed his faculty position at the University of Pittsburgh (1989). Dr. Beckman was promoted to associate professor in 1994, and full professor in 1997, and previously served as Associate Dean for Research for the School of Engineering and Chairman of Chemical Engineering. Dr.

Kristi Anseth

Kristi S. Anseth is a pioneer in biomedical engineering, a leading researcher and inventor in the fields of biomaterials and regenerative medicine. She has shown that by controlling the chemical, biological, and physical properties of biomaterials, fundamental cell biology questions can be probed and the information used in applications to regenerate tissue. Her work on engineering tissues has improved medical treatments for many parts of the body, from helping broken bones heal faster to replacing diseased heart valves. Dr.

Sadik Esener

Sadik Esener, Ph.D., is the director of the Center for Early Detection Research and Wendt Family Endowed Chair in Early Cancer Detection at the Biomedical Engineering Department at OHSU. Prior to joining OHSU, Dr. Esener served in several leadership roles at the University of California, San Diego, in which he achieved results by bringing together scientists and technology across disciplines. He served as the director and principal investigator of the NanoTumor Cancer, a Nanotechnology Center of Excellence funded by the National Cancer Institute.

Maryann Feldman

Maryann P. Feldman is the Heninger Distinguished Professor in the Department of Public Policy at the University of North Carolina, an Adjunct Professor of Finance at Kenan-Flagler Business School and a Research Director at UNC Kenan Institute of Private Enterprise. Her research and teaching interests focus on the areas of innovation, the commercialization of academic research and the factors that promote technological change and economic growth. Dr. Feldman is an editor of the journal, Research Policy, and chairs an interagency working group on Science Policy. From 2014-2017, Dr.

Ken Gall

Professor Gall received his BS, MS, and PhD from the University of Illinois Champaign-Urbana in Mechanical Engineering. He is currently the Chair of Mechanical Engineering and Materials Science at Duke University. His technical expertise is in the creation, modification, understanding, and commercialization of synthetic biomaterials. On the academic side, his materials publications have been cited approximately 16,000 times with an H-index of 69. On the commercial side, he has founded multiple medical device start-ups, including MedShape, Vertera, and Restor3d. MedShape is a fully functioni

Andrés J. García

Andrés J. García is the Executive Director of the Petit Institute for Bioengineering and Bioscience and Regents’ Professor at the Georgia Institute of Technology. He earned a B.S. in Mechanical Engineering with Honors from Cornell University, and M.S.E. and Ph.D. degrees in Bioengineering from the University of Pennsylvania. He completed a post-doctoral fellowship in cell and molecular biology at the School of Medicine of the University of Pennsylvania and then joined the faculty at Georgia Tech in 1998. Dr.

Stephen Gillett

Stephen Gillett is the CEO and cofounder of Alphabet’s moonshot, Chronicle. Gillett joined Chronicle from Google, where he was an executive-in-residence at Google Ventures (GV) and remains an advisor. His leadership experience spans across enterprise software, retail, and consumer technology, including stints as CIO at Starbucks and president of digital and global business services at Best Buy. Gillett most recently served as a senior leader at Google X, working on moonshots.

Natasha Hernday

Natasha Hernday is the Senior Vice President of Corporate Development, and a member of the Executive Committee at Seattle Genetics, Inc. She leads technology licensing, clinical and commercial collaborations, mergers and acquisitions, and corporate strategy projects, and serves on the Board of Directors for PDL BioPharma. Prior to joining Seattle Genetics in January 2011, she spent more than 16 years at Amgen, in roles of increasing responsibility in research, project management and business development finance, before joining the corporate development group in 2000.

Fei Mao

Mr. Fei Mao received his doctorate in chemistry from the University of Oregon in 1990 and has since established a successful career as a researcher, inventor, and entrepreneur in the biotech industry. After receiving his doctorate, Mao first worked at Molecular Probes, Inc. (now part of Thermo Fisher, Co.), where he made a number of inventions in fluorescent dye technologies. Among the inventions is a series of AlexaFluor® dyes, which are now widely used in life science research and diagnostics.

David Mooney

David Mooney is the Robert Pinkas Family Professor of Bioengineering in the Harvard School of Engineering and Applied Sciences, and a Core Faculty Member of the Wyss Institute at Harvard University. He is a member of several national academies and has won numerous awards for his research and his mentorship/teaching. He has published over 400 articles and has been issued numerous patents, several of which have been licensed to companies, resulting in successful commercial products.

Roderic Pettigrew

Roderic Pettigrew, PhD, MD, serves as CEO of Engineering Health (EnHealth) and executive dean for Engineering Medicine (EnMed) at Texas A&M and Houston Methodist Hospital. Dr. Pettigrew also holds the endowed Robert A. Welch Chair in Medical Science. He was the founding Director of the US National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the NIH. EnHealth is the world’s first initiative to holistically integrate engineering into all of the colleges of a university that are a part of the health care enterprise.

August Sick

August Sick operates a private consulting practice focused on start-up to mid-stage biotechnology companies that have a need for experienced operations management, strategic planning and deal expertise, bringing 30+ years of successful executive, entrepreneurial and investment experience. His consulting firm has worked with companies worldwide; most notably leading the licensing of key patents of Sygnis, AG to Qiagen, BV and the sale of the assets of Lab Armor to Sheldon Manufacturing.

Tom Skalak

Tom Skalak joined the Clara Wu and Joe Tsai Foundation in 2018 as Senior Advisor to Clara Wu. The Foundation makes philanthropic investments in science, economic mobility, and the arts, with a vision to produce transformative impact on societal well-being and sustainability. Biomedical sciences and translational research are major directions. Tom is Vice President for Research Emeritus of the University of Virginia and was previously the founding Executive Director of The Paul G. Allen Frontiers Group in Seattle.

Peter Zandstra

Peter Zandstra graduated with a Bachelor of Engineering degree from McGill University in the Department of Chemical Engineering, obtained his Ph.D. degree from the University of British Columbia in the Department of Chemical Engineering and Biotechnology and continued his research training as a Post-Doctoral Fellow in the field of Bioengineering at MIT.  He then began his faculty appointment at the University of Toronto’s Institute of Biomaterial and was later appointed University Professor, the university’s highest academic rank. In July 2017, Dr.